Antiretroviral Agents in HIV-1 (2014)

DHHS Adult HIV 2014

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/282343

Contents of this Issue

Navigation

Page 19 of 23

18 Selecting a Treatment Regimen Table 7b. HIV Drugs (continued) Drug Name Formulations Dosing Recommendations a Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Efavirenz (EFV) Sustiva ® Also available as a component of fixed-dose combination. • 50 and 200 mg capsules • 600 mg tablet • 600 mg once daily, at or before bedtime • Take on an empty stomach to reduce side effects. Rilpivirine (RPV) Edurant ® Also available as a component of fixed-dose combination. 25 mg tablet • 25 mg once daily • Take with a meal. Drug Name Formulations Dosing Recommendations a Characteristics of Protease Inhibitors (PIs) Atazanavir (ATV) Reyataz ® 100, 150, 200, and 300 mg capsules ARV-Naive Patients: • ATV 300 mg + RTV 100 mg once daily; or • ATV 400 mg once daily With TDF or in ARV- Experienced Patients: • ATV 300 mg + RTV 100 mg once daily With EFV in ARV-naive patients: • ATV 400 mg + RTV 100 mg once daily • Take with food. Darunavir (DRV) Prezista ® • 75, 150, 600, and 800 mg tablets • 100 mg/mL oral suspension ARV-Naive Patients or ARV- Experienced Patients with no DRV Mutations: • DRV 800 mg + RTV 100 mg once daily ARV-Experienced Patients with at Least 1 DRV Mutation: • DRV 600 mg + RTV 100 mg bid • DRV inactive without boosting • Take with food.

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 (2014) - DHHS Adult HIV 2014